A close-up of multiple blister packs containing various colored pills.

Enhancing Public Procurement Efficiency in Maldives

SUMMARY  

Access to high quality, and affordable health-care services is critical to strengthening the Maldivian Universal Health Coverage Scheme. To ensure this while also drivingcost efficiencies for the Universal Health Coverage Scheme in Maldives, quality-assured bulk procurement of essential medicines has been identified as an important strategy to achieve economies of scale, resulting in cost- savings, and ultimately contributing towards attainment of the sustainability of the scheme.  

UNDP’s Project Initiation Plan (PIP) with the Government of Maldives is aimed to lay the foundation for procurement of selected medicines at scale, with also a key component of providing technical assistance required to build the necessary supply chain management and logistical planning expertise within national systems and institutions. 

 

BACKGROUND  

The overall objective of the Project is to strengthen the long-term financial sustainability of the Maldives Universal Health Coverage Scheme — "Aasandha” . 

UNDP’s assistance in procuring quality-assured medicines at scale is expected to streamline the delivery time and the costs. The potential savings and service efficiency from this project can be reallocated towards improving the quality of healthcare services in the Maldives, which can increase the coverage of existing social protection mechanisms and public health service delivery channels across the country, especially in the outer islands of Maldives through allocative efficiency.  

The initiative links Maldives to global medicine supply chains through UNDP Global Long Term Agreement holders, ensuring broader and wider access to manufacturers and suppliers all over the world. The UNDP's procurement approach follows a stringent quality assurance process, and ensures high-quality health products from WHO-approved manufacturers, along with robust transparency and risk management practices. 

For more information on UNDP Quality Assurance Process for Health Products see: https://popp.undp.org/policy-page/quality-assurance-health-products. 

 
 

PROJECT OUTCOMES 

 

  1. Enhancing cost efficiency in medicine procurement through bulk purchasing
  2. Providing technical advisory/capacity building on health financing, data management, public procurement and strengthening medicine legal framework 

GEWE / GESI COMPONENT 

Gender responsiveness will be mainstreamed throughout the project.  

 

ACHIEVEMENTS  

Based on needs identified and orders placed by the national partners, the medicines below have been procured through this project thus far. 

 

PROCUREMENT DETAIL

    Procured and Delivered

    Insulin Analogue long acting, Glargine, 100IU/ml, injectable solution
    Insulin Analogue rapid, Aspart, 100IU/ml, injectable solution
    Ceftriaxone, 1g powe
    Diclofenac, 50mg
    Meropenem trihydrate 1000 mg,
    Vildagliptin, 50mg,
    Vildagliptin + Metformin, 50mg + 1000mg
    Carbamazepine, 100mg/5ml, oral solution
    Carbamazepine, 200mg
    Fluoxetine, 20mg

      Procured and Delivered

      Phenobarbital (sodium), 200mg/ml
      Diazepam, 2mg
      Ceftriaxone (sodium), 500mg
      Amoxicillin/Clavulanic acid, 1000mg/200mg
      Lorazepam, 1m
      Indacaterol (maleate)/Glycopyrronium (bromide), 110mcg/50mcg
      Carbamazepine, 200mg
      Diclofenac (sodium), 50mg
      Meropenem trihydrate 1000 mg
      Insulin Analogue rapid, Aspart, 100IU/ml, injectable solution, 3ml  
      Insulin Analogue long acting, Glargine, 100IU/ml, injectable solution, 3ml 

       

        Procured and Delivered

        Ceftriaxone (sodium), 500mg
        Lidocaine HCl 2% injection 20 ml 
        Water for injection 10 ml

         

        Order in Progress

        Entecavir, 0.5mg

          Procured and Delivered
           

          Fenorfibrate Capsule 200 mg
          Escitalopram Tablet 10 mg
          Gabapentin Tablet 100 mg
          Gabapentin Tablet 300 mg
          Rivaroxaban Tablet 10 mg
          Montelukast Chewable Tablet 5 mg
          Insulin Glargine 100 IU 
          Itraconazole 100 mg



          Order in Progress

          Mycophenolate Mofetil 500mg
          Prazosin 5mg
          Oxcarbazepine 300mg
          Insulin, aspart, 100 U/ml, solution for injection
          piperacillin 4 g + tazobactam 500 mg
          benzhexol HCl (trihexyphenidyl) 2 mg
          Montelukast 10mg film-coated tablet
          Cefuroxime 1.5g 
          Aspirin 75mg E/C 
          Azithromycin 500 mg
          Mycophenolate Mofetil 500mg 
          Fluticasone Propionate Nasal Spray 50 mcg 
          Montelukast Tablet (IR) 10 mg

          Related Materials

          Impact

          START DATE

          January 2025

          END DATE

          December 2026

          STATUS

          Ongoing

          PROJECT OFFICE

          Maldives

          IMPLEMENTING PARTNER

          UNDP

          DONORS

          GOVERNMENT OF MALDIVES

          TOTAL CONTRIBUTIONS

          $2,844,464

          DELIVERY IN PREVIOUS YEARS

          2025$82,063

          2026$590,583

          Full Project information